| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |